Atrás

Watch Compare

HERON THERAPEUTICS, INC. /DE/

Calidad de datos: 83%

HRTX

Nasdaq Manufacturing Chemicals

$0.82

▼ $0.01 (-1.44%)

Cap. Mercado: 154.66 M

Precio

$0.82

Cap. Mercado

154.66 M

Rango del Día

$0.80 — $0.83

Rango de 52 Semanas

$0.74 — $2.61

Volumen

1,019,274

Apertura $0.83

Promedio 50D / 200D

$1.07

23.66% below

Promedio 50D / 200D

$1.35

39.35% below

Quick Summary

Puntos Clave

Negative free cash flow of -27.91 M

Crecimiento

Revenue Growth (5Y)

N/A

Revenue (1Y)N/A

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Calidad

Return on Equity

N/A

ROIC-3.02%

Net MarginN/A

Op. MarginN/A

Seguridad

Debt / Equity

N/A

Current Ratio2.56

Interest Coverage-0.26

Valoración

PE (TTM)

-7.66

Below sector avg (-1.48)

P/B Ratio10.39

EV/EBITDAN/A

Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)

Métrica	Acción	Mediana del Sector
P/E	-7.7	-1.5
P/B	10.4	1.6
ROE %	—	-53.4
Net Margin %	—	-41.5
Rev Growth 5Y %	—	1.8
D/E	—	0.3

ETFs Holding This Stock

GMAPX GMAPX

0.06% weight

GCSIX GCSIX

0.06% weight

GCSSX GCSSX

0.06% weight

GCSAX GCSAX

0.06% weight

GCSCX GCSCX

0.06% weight

GDSRX GDSRX

0.06% weight

GDSTX GDSTX

0.06% weight

GCSUX GCSUX

0.06% weight

GSXPX GSXPX

0.04% weight

GSATX GSATX

0.04% weight

All Fundamental Metrics

Growth
Revenue Growth (1Y)	N/A	Revenue Growth (3Y)	N/A
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	N/A	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	N/A	Net Income (TTM)	-20.20 M
ROE	N/A	ROA	-8.40%
Gross Margin	N/A	Operating Margin	N/A
Net Margin	N/A	Free Cash Flow (TTM)	-27.91 M
ROIC	-3.02%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	N/A	Current Ratio	2.56
Interest Coverage	-0.26	Asset Turnover	N/A
Working Capital	139.69 M	Tangible Book Value	14.89 M
Dividends
Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	-7.66	Forward P/E	N/A
P/B Ratio	10.39	P/S Ratio	N/A
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	-18.05%
Market Cap	154.66 M	Enterprise Value	111.59 M
Per Share
EPS (Diluted TTM)	-0.12	Revenue / Share	N/A
FCF / Share	-0.15	OCF / Share	-0.15
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A
Efficiency
CapEx / Revenue	N/A	FCF Conversion	138.19%
SBC-Adj. FCF	-38.79 M	Growth Momentum	N/A

Income Statement

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	—	—	—	—	—
Net Income	-20.20 M	-13.58 M	-110.56 M	-182.02 M	-220.68 M
EPS (Diluted)	-0.12	-0.09	-0.80	-1.67	—
Gross Profit	113.56 M	105.64 M	61.94 M	—	—
Operating Income	-2.54 M	-11.53 M	-110.62 M	-174.66 M	-217.83 M
EBITDA	—	—	—	—	—
R&D Expenses	12.43 M	16.68 M	55.90 M	107.51 M	130.82 M
SG&A Expenses	—	—	—	—	—
D&A	2.31 M	2.49 M	2.90 M	2.89 M	3.02 M
Interest Expense	9.61 M	6.03 M	3.87 M	2.47 M	2.41 M
Income Tax	0.0	0.0	0.0	0.0	0.0

Balance Sheet

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	255.88 M	233.15 M	222.51 M	250.95 M	305.71 M
Total Liabilities	241.54 M	266.80 M	256.48 M	237.38 M	228.14 M
Shareholders' Equity	14.33 M	-33.65 M	-33.97 M	13.57 M	77.57 M
Total Debt	—	—	—	—	—
Cash & Equivalents	28.65 M	25.80 M	28.68 M	15.36 M	90.54 M
Current Assets	238.07 M	209.01 M	188.77 M	205.44 M	254.42 M
Current Liabilities	96.10 M	91.46 M	79.69 M	82.36 M	71.06 M